A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure
Author:
- 1 March 1990
- journal article
- clinical trial
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (2) , 419-425
Abstract
OPC-8212 is a newly synthesized, orally effective inotropic agent. Previous studies have shown short-term hemodynamic and symptomatic improvement in patients with congestive heart failure. However, the long-term efficacy of this agent remains to be established. Eighty-three patients with chronic heart failure were randomly assigned to treatment with either OPC-8212 (n=45) or matching placebo (n-38). Of the placebo-treated patients, two patients died and another six patients were withdrawn from the study because of a deterioration of heart failure, while only 1 out of 45 OPC-8212-treated patients were withdrawn because of increased congestive symptoms. After 12 weeks of treatment, the OPC-8212 group showed a significant improvement in their numerical scores in sense of well-being as judged by the patients' subscale A (p<0.01) and their physician's general impression of the patients' status (p<0.01). The ejection fraction obtained from echocardiography increased from a mean (±SEM) baseline value of 42.8±2.6% to 46.6±2.9% (p<0.05) in the OPC-8212 group and 44.4±3.7% to 45.5±4.1% in the placebo group. These effects were not associated with an increase in the heart rate. The treatment was well tolerated without any limiting side effects. Thus, OPC-8212 is effective in patients with chronic heart failure, providing significant hemodynamic and symptomatic benefit in chronic treatment, together with a possible improvement of the prognosis of patients with heart failure.Keywords
This publication has 22 references indexed in Scilit:
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Long-term indoramin therapy in congestive heart failure: A double-blind, randomized, parallel placebo-controlled trialJACC, 1987
- Physician practice in the management of congestive heart failureJACC, 1986
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Hemodynamic and Electrophysiological Effects of a Novel Positive Inotropic Drug, OPC-8212, in Normal and “Failing” Guinea Pig Heart PreparationsJournal of Cardiovascular Pharmacology, 1986
- Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failureHeart and Vessels, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized DogsJournal of Cardiovascular Pharmacology, 1986
- Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone and related compounds.Chemical and Pharmaceutical Bulletin, 1984
- Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.Circulation, 1981